• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of LIM homeodomain transcription factor ISL-1 in leukemogenesis in ATL

Research Project

Project/Area Number 15K18414
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Tumor biology
Research InstitutionUniversity of the Ryukyus

Principal Investigator

ISHIKAWA Chie  琉球大学, 亜熱帯島嶼科学超域研究推進機構, 助教 (90542358)

Project Period (FY) 2015-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywords成人T細胞白血病(ATL) / HTLV-1 / ISL-1 / Tax / c-myc / 成人T細胞白血病
Outline of Final Research Achievements

HTLV-1 is the etiological agent of adult T-cell leukemia (ATL). Although the viral protein Tax plays crucial roles for the development of ATL, the underlying mechanisms remain obscure. ISL-1, LIM homeodomain transcription factor, is specifically expressed in certain tissue types only. Recently, ISL-1 is suggested to play an oncogenic role. The expression of ISL-1 was assessed in 8 HTLV-1-infected T-cell lines and 3 uninfected T-cell lines. RT-PCR results demonstrated a marked highly expression of ISL-1 mRNA in 5 HTLV-1-infected T-cell lines. The expression levels of ISL-1 mRNA were associated with those of Tax mRNA. ISL-1 protein was also detected in 3 Tax-positive HTLV-1-infected T-cell lines. HTLV-1 infection and Tax overexpression induced the expression of ISL-1 in T cells. Notably, ISL-1 overexpression promoted T-cell proliferation. Furthermore, ISL-1 activated the expression of c-myc. Our results provide insights into the new relationships between ISL-1 and HTLV-1 oncogenesis.

Report

(3 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • Research Products

    (16 results)

All 2017 2016 2015

All Journal Article (4 results) (of which Peer Reviewed: 4 results,  Acknowledgement Compliant: 2 results) Presentation (12 results)

  • [Journal Article] Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines.2017

    • Author(s)
      Chie Ishikawa, Masachika Senba, Naoki Mori.
    • Journal Title

      Oncology Letters

      Volume: 印刷中

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cel lines.2016

    • Author(s)
      Chie Ishikawa, Takahiro Jomori, Junichi Tanaka, Masachika Senba, Naoki Mori.
    • Journal Title

      International Journal of Oncology

      Volume: 49 Issue: 4 Pages: 1713-1721

    • DOI

      10.3892/ijo.2016.3648

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Efficiency of AUY922 in mice with adult T-cell leukemia/lymphoma2016

    • Author(s)
      Chie Ishikawa, Masachika Senba, Naoki Mori.
    • Journal Title

      Oncology Letters

      Volume: 印刷中

    • Related Report
      2015 Research-status Report
    • Peer Reviewed
  • [Journal Article] Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD302015

    • Author(s)
      Chie Ishikawa, Masachika Senba, Naoki Mori.
    • Journal Title

      International Journal of Oncology

      Volume: 47 Issue: 6 Pages: 2197-2207

    • DOI

      10.3892/ijo.2015.3218

    • Related Report
      2015 Research-status Report
    • Peer Reviewed
  • [Presentation] Effets of fucoidan against KSHV-related primary effusion lymphoma both in vitro and in vivo.2016

    • Author(s)
      Chie Ishikawa, Naoki Mori.
    • Organizer
      The 64th Annual Meeting of the Japanese Society for Virology.
    • Place of Presentation
      札幌コンベンションセンター(北海道札幌市)
    • Year and Date
      2016-10-23
    • Related Report
      2016 Annual Research Report
  • [Presentation] Anti-ATL activity of cerdulatinib, a novel dual SYK/JAK kinase inhibitor.2016

    • Author(s)
      Naoki Mori, Chie Ishikawa.
    • Organizer
      The 64th Annual Meeting of the Japanese Society for Virology.
    • Place of Presentation
      札幌コンベンションセンター(北海道札幌市)
    • Year and Date
      2016-10-23
    • Related Report
      2016 Annual Research Report
  • [Presentation] Targeting mitotic kinase PBK/TOPK decreases growth and survival of HTLV-1-infected T-cell lines.2016

    • Author(s)
      Naoki Mori, Chie Ishikawa.
    • Organizer
      The 78th Annucal Meeting of the Japanese Society of Hematology.
    • Place of Presentation
      パシフィコ横浜(神奈川県横浜市)
    • Year and Date
      2016-10-13
    • Related Report
      2016 Annual Research Report
  • [Presentation] Activity of the novel dual SYK/JAK kinase inhibitor cerdulatinib against ATL.2016

    • Author(s)
      Chie Ishikawa, Naoki Mori.
    • Organizer
      The 75th Annual Meeting of the Japanese Cancer Association.
    • Place of Presentation
      パシフィコ横浜(神奈川県横浜市)
    • Year and Date
      2016-10-06
    • Related Report
      2016 Annual Research Report
  • [Presentation] Mitotic kinase PBK/TOPK as a therapeutic target for ATL.2016

    • Author(s)
      Naoki Mori, Chie Ishikawa.
    • Organizer
      The 75th Annual Meeting of the Japanese Cancer Association.
    • Place of Presentation
      パシフィコ横浜(神奈川県横浜市)
    • Year and Date
      2016-10-06
    • Related Report
      2016 Annual Research Report
  • [Presentation] ATLの新規治療標的分子PBK/TOPK2016

    • Author(s)
      森直樹、石川千恵
    • Organizer
      第3回日本HTLV-1学会学術集会
    • Place of Presentation
      鹿児島県市町村自治会館(鹿児島県鹿児島市)
    • Year and Date
      2016-08-26
    • Related Report
      2016 Annual Research Report
  • [Presentation] Inhibition of proliferation and survival of HTLV-1-infected T-cell lines by peridinin.2015

    • Author(s)
      Naoki Mori, Chie Ishikawa, Jun-ichi Tanaka.
    • Organizer
      The 63rd Annual Meeting of the Japanese Society for Virology.
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Year and Date
      2015-11-22
    • Related Report
      2015 Research-status Report
  • [Presentation] Activity of the novel dual PI3K/mTOR inhibitor BEZ235 against ATL.2015

    • Author(s)
      Chie Ishikawa, Naoki Mori.
    • Organizer
      The 63rd Annual Meeting of the Japanese Society for Virology.
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Year and Date
      2015-11-22
    • Related Report
      2015 Research-status Report
  • [Presentation] Pim-3 kinase as a therapeutic target for ATL.2015

    • Author(s)
      Naoki Mori, Chie Ishikawa.
    • Organizer
      The 77th Annucal Meeting of the Japanese Society of Hematology.
    • Place of Presentation
      石川県立音楽堂(金沢市)
    • Year and Date
      2015-10-16
    • Related Report
      2015 Research-status Report
  • [Presentation] Activity of the novel dual PI3K/mTOR inhibitor BEZ235 against ATL.2015

    • Author(s)
      Chie Ishikawa, Naoki Mori.
    • Organizer
      The 74th Annual Meeting of the Japanese Cancer Association.
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2015-10-08
    • Related Report
      2015 Research-status Report
  • [Presentation] Pim-3 kinase as a therapeutic target for ATL.2015

    • Author(s)
      Naoki Mori, Chie Ishikawa.
    • Organizer
      The 74th Annual Meeting of the Japanese Cancer Association.
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2015-10-08
    • Related Report
      2015 Research-status Report
  • [Presentation] ATLに選択的に発現しているPim-3を分子標的とした新たな治療法の開発2015

    • Author(s)
      森直樹、石川千恵
    • Organizer
      第2回日本HTLV-1学会学術集会
    • Place of Presentation
      東京大学医科学研究所講堂(東京都港区)
    • Year and Date
      2015-08-21
    • Related Report
      2015 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi